Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
4.810
-0.010 (-0.21%)
At close: Feb 21, 2025, 4:00 PM
4.700
-0.110 (-2.29%)
After-hours: Feb 21, 2025, 4:30 PM EST
Genelux Market Cap
Genelux has a market cap or net worth of $164.04 million as of February 21, 2025. Its market cap has decreased by -27.60% in one year.
Market Cap
164.04M
Enterprise Value
132.03M
1-Year Change
-27.60%
Ranking
Category
Stock Price
$4.81
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has increased from $141.69M to $164.04M, an increase of 15.77%. That is a compound annual growth rate of 7.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 164.04M | 103.81% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |